2,188
Views
40
CrossRef citations to date
0
Altmetric
Original Research

High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer

, , , , , , , , , ORCID Icon & show all
Article: e1390640 | Received 30 Jun 2017, Accepted 05 Oct 2017, Published online: 06 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Mine Ozcan, Jonas Janikovits, Magnus von Knebel Doeberitz & Matthias Kloor. (2018) Complex pattern of immune evasion in MSI colorectal cancer. OncoImmunology 7:7.
Read now

Articles from other publishers (38)

Javier Ros, Iosune Baraibar, Nadia Saoudi, Marta Rodriguez, Francesc Salvà, Josep Tabernero & Elena Élez. (2023) Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers. Cancers 15:17, pages 4245.
Crossref
Luana Greco, Federica Rubbino, Arianna Dal Buono & Luigi Laghi. (2023) Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability—Lessons from Colorectal Cancer. Genes 14:6, pages 1169.
Crossref
Minghong Pan, Yuanyong Wang, Zhaoyang Wang, Changjian Shao, Yingtong Feng, Peng Ding, Hongtao Duan, Xiaoya Ren, Weixun Duan, Zhiqiang Ma & Xiaolong Yan. (2023) Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma. Aging.
Crossref
Sheng-Nan Ren, Zhan-Yi Zhang, Rui-Jie Guo, Da-Ren Wang, Fang-Fang Chen, Xue-Bo Chen & Xue-Dong Fang. (2023) Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. World Journal of Gastroenterology 29:13, pages 1911-1941.
Crossref
Mariarosaria Conte, Annabella Di Mauro, Lucia Capasso, Liliana Montella, Mariacarla De Simone, Angela Nebbioso & Lucia Altucci. (2023) Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer. Cancers 15:7, pages 1960.
Crossref
SriPragnya Cheruku, Vanishree Rao, Ruchi Pandey, Mallikarjuna Rao Chamallamudi, Ravichandiran Velayutham & Nitesh Kumar. (2023) Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy. International Immunopharmacology 116, pages 109569.
Crossref
Núria Mulet-Margalef, Jenniffer Linares, Jordi Badia-Ramentol, Mireya Jimeno, Carolina Sanz Monte, José Luis Manzano Mozo & Alexandre Calon. (2023) Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape. Cancers 15:4, pages 1022.
Crossref
Mikal El-Hajjar, Lara Gerhardt, Megan M Y Hong, Mithunah Krishnamoorthy, Rene Figueredo, Xiufen Zheng, James Koropatnick & Saman Maleki Vareki. (2023) Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory. Molecular Therapy 31:2, pages 535-551.
Crossref
Shuting Han, Aik Yong Chok, Daniel Yang Yao Peh, Joshua Zhi-Ming Ho, Emile Kwong Wei Tan, Si-Lin Koo, Iain Bee-Huat Tan & Johnny Chin-Ann Ong. (2022) The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers. Frontiers in Genetics 13.
Crossref
Zhengkui Zhang, Xiangjun Kong, Maarten A. Ligtenberg, Susan E. van Hal-van Veen, Nils L. Visser, Beaunelle de Bruijn, Kelly Stecker, Pim W. van der Helm, Thomas Kuilman, Esmée P. Hoefsmit, David W. Vredevoogd, Georgi Apriamashvili, Beau Baars, Emile E. Voest, Sjoerd Klarenbeek, Maarten Altelaar & Daniel S. Peeper. (2022) RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells. Cell Reports Medicine 3:6, pages 100655.
Crossref
Chenzhi Zhang, Dandan Li, Binyi Xiao, Chi Zhou, Wu Jiang, Jinghua Tang, Yuan Li, Rongxin Zhang, Kai Han, Zhenlin Hou, Linjie Zhang, Qiaoqi Sui, Leen Liao, Zhizhong Pan, Xiaoshi Zhang & Peirong Ding. (2022) B2M and JAK1/2–mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy. Journal of Immunotherapy 45:4, pages 187-193.
Crossref
Lena Bohaumilitzky, Klaus Kluck, Robert Hüneburg, Richard Gallon, Jacob Nattermann, Martina Kirchner, Glen Kristiansen, Oliver Hommerding, Pauline L. Pfuderer, Lelia Wagner, Fabian Echterdiek, Svenja Kösegi, Nico Müller, Konstantin Fischer, Nina Nelius, Ben Hartog, Gillian Borthwick, Elena Busch, Georg Martin Haag, Hendrik Bläker, Gabriela Möslein, Magnus von Knebel Doeberitz, Toni T. Seppälä, Maarit Ahtiainen, Jukka-Pekka Mecklin, D. Timothy Bishop, John Burn, Albrecht Stenzinger, Jan Budczies, Matthias Kloor & Aysel Ahadova. (2022) The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. Gastroenterology 162:3, pages 907-919.e10.
Crossref
Sanne W. Bajwa - ten Broeke, Alexej Ballhausen, Aysel Ahadova, Manon Suerink, Lena Bohaumilitzky, Florian Seidler, Hans Morreau, Tom van Wezel, Julia Krzykalla, Axel Benner, Noel F. de Miranda, Magnus von Knebel Doeberitz, Maartje Nielsen & Matthias Kloor. (2021) The coding microsatellite mutation profile of PMS2-deficient colorectal cancer. Experimental and Molecular Pathology 122, pages 104668.
Crossref
Hanbing Wang, Baorui Liu & Jia Wei. (2021) Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy. Cancer Letters 517, pages 96-104.
Crossref
Peixin Chen, Lishu Zhao, Hao Wang, Liping Zhang, Wei Zhang, Jun Zhu, Jia Yu, Sha Zhao, Wei Li, Chenglong Sun, Chunyan Wu, Yayi He & Caicun Zhou. (2021) Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer. Journal for ImmunoTherapy of Cancer 9:8, pages e002554.
Crossref
Danielle M. Pastor & Jeffrey Schlom. (2021) Immunology of Lynch Syndrome. Current Oncology Reports 23:8.
Crossref
Giovanni Germano, Steve Lu, Giuseppe Rospo, Simona Lamba, Benoit Rousseau, Sonia Fanelli, Denise Stenech, Dung T. Le, John Hays, Maria Grazia Totaro, Vito Amodio, Rosaria Chilà, Anna Mondino, Luis A. DiazJr.Jr., Federica Di Nicolantonio & Alberto Bardelli. (2021) CD4 T Cell–Dependent Rejection of Beta-2 Microglobulin Null Mismatch Repair–Deficient Tumors. Cancer Discovery 11:7, pages 1844-1859.
Crossref
Juan Zhang, Qi Tian, Mi Zhang, Hui Wang, Lei Wu & Jin Yang. (2021) Immune-related biomarkers in triple-negative breast cancer. Breast Cancer 28:4, pages 792-805.
Crossref
Elena Busch, Aysel Ahadova, Kosima Kosmalla, Lena Bohaumilitzky, Pauline L. Pfuderer, Alexej Ballhausen, Johannes Witt, Jan-Niklas Wittemann, Hendrik Bläker, Elke Holinski-Feder, Dirk Jäger, Magnus von Knebel Doeberitz, Georg Martin Haag & Matthias Kloor. (2021) Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers. Frontiers in Oncology 11.
Crossref
Aysel Ahadova, Pauline Luise Pfuderer, Maarit Ahtiainen, Alexej Ballhausen, Lena Bohaumilitzky, Svenja Kösegi, Nico Müller, Yee Lin Tang, Kosima Kosmalla, Johannes Witt, Volker Endris, Albrecht Stenzinger, Magnus von Knebel Doeberitz, Hendrik Bläker, Laura Renkonen-Sinisalo, Anna Lepistö, Jan Böhm, Jukka-Pekka Mecklin, Toni T. Seppälä & Matthias Kloor. (2021) Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance. Journal of Clinical Medicine 10:11, pages 2458.
Crossref
Asima Abidi, Mark A. J. Gorris, Evan Brennan, Marjolijn C. J. Jongmans, Dilys D. Weijers, Roland P. Kuiper, Richarda M. de Voer, Nicoline Hoogerbrugge, Gerty Schreibelt & I. Jolanda M. de Vries. (2021) Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome. Cancers 13:10, pages 2345.
Crossref
Hee Young Na, Yujun Park, Soo Kyung Nam, Kyu Sang Lee, Heung‐Kwon Oh, Duck‐Woo Kim, Sung‐Bum Kang, Woo Ho Kim & Hye Seung Lee. (2020) Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact. Cancer Science 112:1, pages 91-100.
Crossref
Jin-Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiao-Jie Lu & Jiansong Ji. (2020) Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomarker Research 8:1.
Crossref
Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, Yongzhen Mo, Xiaoxu Wei, Yunhua Chen, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Zhaoyang Zeng & Wei Xiong. (2020) Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Molecular Cancer 19:1.
Crossref
Lena Bohaumilitzky, Magnus von Knebel Doeberitz, Matthias Kloor & Aysel Ahadova. (2020) Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review. Journal of Clinical Medicine 9:6, pages 1741.
Crossref
Emilie Picard, Chris P. Verschoor, Grace W. Ma & Graham Pawelec. (2020) Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Frontiers in Immunology 11.
Crossref
Zuzana Snahnicanova, Ivana Kasubova, Michal Kalman, Marian Grendar, Peter Mikolajcik, Eva Gabonova, Ludovit Laca, Martin Caprnda, Luis Rodrigo, Rachele Ciccocioppo, Peter Kruzliak, Lukas Plank & Zora Lasabova. (2019) Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer. Clinical and Experimental Medicine 20:1, pages 87-95.
Crossref
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Tumor Immunology and Immunotherapy – Integrated Methods Part B xvii xxxvi .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part A. Tumor Immunology and Immunotherapy – Integrated Methods Part A xix xxxviii .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Tumor Immunology and Immunotherapy – Cellular Methods Part B xxiii xlii .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part A. Tumor Immunology and Immunotherapy – Cellular Methods Part A xxiii xlii .
Sumit Middha, Rona Yaeger, Jinru Shia, Zsofia K. Stadler, Sarah King, Shanna Guercio, Victoriya Paroder, David D.B. Bates, Satshil Rana, Luis A. DiazJrJr, Leonard Saltz, Neil Segal, Marc Ladanyi, Ahmet Zehir & Jaclyn F. Hechtman. (2019) Majority of B2M -Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High . JCO Precision Oncology:3, pages 1-14.
Crossref
Bruno Augusto Alves Martins, Gabriel Fonseca de Bulhões, Igor Norat Cavalcanti, Mickaella Michelson Martins, Paulo Gonçalves de Oliveira & Aline Maria Araújo Martins. (2019) Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research. Frontiers in Oncology 9.
Crossref
Pauline L. Pfuderer, Alexej Ballhausen, Florian Seidler, Hans-Jürgen Stark, Niels Grabe, Ian M. Frayling, Ann Ager, Magnus von Knebel Doeberitz, Matthias Kloor & Aysel Ahadova. (2019) High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer. British Journal of Cancer 121:5, pages 395-404.
Crossref
Anne Ackermann, Christopher Schrecker, Dimitra Bon, Nicolaus Friedrichs, Katrin Bankov, Peter Wild, Guido Plotz, Stefan Zeuzem, Eva Herrmann, Martin-Leo Hansmann & Angela Brieger. (2019) Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer. PLOS ONE 14:3, pages e0213411.
Crossref
Laetitia Nebot-Bral, Clelia Coutzac, Patricia L. Kannouche & Nathalie Chaput. (2019) Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?. Bulletin du Cancer 106:2, pages 105-113.
Crossref
Kim Wong, Louise van der Weyden, Courtney R. Schott, Alastair Foote, Fernando Constantino-Casas, Sionagh Smith, Jane M. Dobson, Elizabeth P. Murchison, Hong Wu, Iwei Yeh, Douglas R. Fullen, Nancy Joseph, Boris C. Bastian, Rajiv M. Patel, Inigo Martincorena, Carla Daniela Robles-Espinoza, Vivek Iyer, Marieke L. Kuijjer, Mark J. Arends, Thomas Brenn, Paul W. Harms, Geoffrey A. Wood & David J. Adams. (2019) Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nature Communications 10:1.
Crossref
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2019. Tumor Immunology and Immunotherapy – Molecular Methods. Tumor Immunology and Immunotherapy – Molecular Methods xxi xl .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.